PepLabo Download

Wegovy® (injection) and hiccups

Hiccups on Wegovy® injection: the one label sentence that names them, the nearby reflux and burping rates, EU and Canadian data, and when to call.

Published · Updated · Wegovy®: side effects by symptom · Written by the PepLabo editorial team

When to get help
Context and scope

Hiccups are easy to dismiss until they keep coming back after each weekly Wegovy® injection. The US label does mention them, but only once, inside a paragraph rather than a table, so many summaries miss it. This page shows where that mention sits, what the European and Canadian product information add, and which general guidance covers hiccups that will not stop.

Key takeaways 5
  • The US label names hiccups in its gastrointestinal paragraph for adults on the injection, next to indigestion, burping, reflux and gastritis, as more frequent than with placebo. [1]
  • The same paragraph says these reactions were reported most often during dose escalation. [1]
  • Neither the EU summary of product characteristics nor the Canadian monograph lists hiccups in its adverse reaction tables. [2][3]
  • The neighbouring reactions do have numbers: reflux 5% vs 3% and burping 7% vs under 1% in the adult 2.4 mg pool. [1]
  • General guidance treats hiccups lasting longer than two days as persistent and a reason to contact a provider. [6]

One sentence, no percentage

Section 6.1 of the Wegovy® prescribing information describes gastrointestinal reactions in adults treated with the injection for weight reduction. After the headline figures for nausea, vomiting and diarrhea, it lists other reactions seen at a higher incidence than with placebo: indigestion, abdominal pain, swelling of the abdomen, burping, gas, reflux, gastritis, hemorrhoids and hiccups. It adds that these reactions were reported most often during dosage escalation. [1]

That is the only place hiccups appear. Table 3, the main adult table, includes a reaction only when at least 2% of people on Wegovy® reported it and it was more frequent than on placebo. A reaction mentioned in the text but absent from the table missed at least one of those two tests, and the label does not say which. [1] The table below lines up what each official source says.

Hiccups in Wegovy® product information (checked 20-10-2026)
Source and populationHiccupsClosest rows with numbers (Wegovy® vs placebo)
US label, adults, 2.4 mg injection pool (68 weeks) [1]Named in text; no rateReflux 5% vs 3%; burping 7% vs <1%; indigestion 9% vs 3%; gastritis 4% vs 1%
US label, adults, 7.2 mg trials (72 weeks) [1]Not mentionedNausea 39% vs 13%; vomiting 22% vs 6%
US label, adolescents 12+ [1]Not mentionedBurping 4% vs 0%; reflux 4% vs 2%
EU SmPC section 4.8 (STEP 1–4 pool) [2]Not listedReflux, gastritis, indigestion and burping: “common” (1 in 100 to 1 in 10)
Canadian monograph, Table 4 (≥1%, STEP 1–3) [3]Not listedBurping 7.4% vs 0.4%; reflux 5.4% vs 3.0%

What studies have looked at

Our PubMed search on 20 October 2026 found no trial analysis or case report about hiccups with semaglutide, the active ingredient in Wegovy®. A pharmacovigilance study of FDA safety reports from 2018 to 2022 did count 47 hiccup reports with semaglutide (all brands together), more often than with other medicines in the database [7]; such reports cannot show cause or frequency. So the label sentence remains the strongest Wegovy®-specific evidence, and it comes without a rate or a duration.

Research is more developed for reflux, the reaction most often discussed as a hiccup trigger. A population-based cohort from the UK followed adults with type 2 diabetes who started a GLP-1 medicine or an SGLT-2 inhibitor. Over a median of three years, the GLP-1 group had a higher risk of a new reflux diagnosis (risk ratio 1.27; 0.7 extra cases per 100 people). [4] This was an observational study of people with diabetes using several GLP-1 medicines, not Wegovy® at weight-management doses, and the authors note that diet and lifestyle could not be fully accounted for.

Why hiccups could follow a dose

It helps to separate what the label supports from what is only proposed.

  • Supported by the label: Wegovy® slows stomach emptying, and its gastrointestinal reactions, including reflux and burping, cluster in the weeks when the dose steps up. [1]
  • Proposed but not measured for Wegovy®: hiccups start when the nerves that control the diaphragm, including the vagus and phrenic nerves, are irritated, and reflux and gastritis are recognised causes of longer-lasting hiccups. [6] A fuller, slower stomach and acid reflux could plausibly irritate this reflex, but no study has tested that chain with Wegovy®.
  • General knowledge: short bouts often follow eating a lot or quickly, fizzy drinks, swallowing air, alcohol, or very spicy, hot or cold food. [6] Often there is no clear trigger at all. [5]

Causes unrelated to the injection

Hiccups that last for days have a wider list of possible causes. Cleveland Clinic names digestive conditions such as reflux and gastritis, conditions of the brain and nervous system such as stroke, metabolic problems including kidney failure, infections such as flu or shingles, some medicines including certain chemotherapy drugs, and recent surgery or anaesthesia. [6] MedlinePlus adds irritation of the nerves to the diaphragm from conditions such as pneumonia or pleurisy, and harmful fumes. [5]

A new medicine started around the same time, a chest infection or a recent procedure can therefore matter as much as the injection itself. Mentioning all of them to your clinician gives a fuller picture.

What general guidance suggests

The Wegovy® Medication Guide gives no specific advice for hiccups. [1] General sources say there is no guaranteed way to stop a bout. MedlinePlus lists simple measures people commonly try, such as holding the breath, sipping cold water or breathing repeatedly into a paper bag. [5] Cleveland Clinic suggests looking at triggers: eating more slowly, smaller portions, and fewer fizzy or alcoholic drinks. [6]

For hiccups that do not settle, a clinician may look for an underlying cause and can consider medicines or other treatments. [5] Do not try neck massage on yourself; MedlinePlus says this is something only a provider should do. [5] If heartburn seems to come with the hiccups, ask a pharmacist before starting any remedy, because some medicines interact with others you take.

Wegovy® details that shape the picture

Wegovy® injection is given once a week, and the label raises the dose every 4 weeks during escalation. [1] If a step is not tolerated, the label gives prescribers the option of delaying the next one; that is their decision, not something to change on your own. [1]

The hiccups sentence refers to adults on the injection. For the 25 mg tablets, the label says only that the types and frequency of common reactions were similar to Table 3, without naming hiccups. [1] The adolescent section lists burping, reflux and indigestion among teenagers’ gastrointestinal reactions, but not hiccups. [1]

Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help

The signs and contact information below come from this article’s sourced guidance.

Emergency

  • Swelling of the face, lips or throat, or trouble breathing or swallowing

    Contact: Stop Wegovy® and get emergency help (911 or local number)

    Medication Guide [1]

Today

  • Severe stomach pain that will not go away, with or without vomiting, sometimes reaching the back

    Contact: Stop Wegovy® and call your prescriber right away

    Medication Guide [1]

  • Vomiting, nausea or diarrhea that does not go away alongside the hiccups

    Contact: Prescriber, promptly (risk of dehydration)

    Medication Guide [1]

  • Hiccups lasting longer than two days

    Contact: Your prescriber or primary care provider

    Cleveland Clinic [6]

At your next appointment

  • Hiccups that return after each dose step, with reflux or burping

    Contact: Mention at your next visit

    Label §6.1 [1]

Questions

Are hiccups listed as a Wegovy® side effect?

Yes, in the US label text: hiccups are named among gastrointestinal reactions that were more frequent than with placebo in adults on the injection. They have no percentage and are not in the Medication Guide’s list of most common side effects. [1]

Why do my hiccups seem worse the week my dose goes up?

The label says Wegovy®’s gastrointestinal reactions, the group that includes hiccups, were reported most often during dose escalation. It does not give a timeline for hiccups specifically. [1]

Do Wegovy® tablets cause hiccups too?

The label names hiccups only for adults on the injection. For the 25 mg tablets it says the common reactions were similar in type and frequency to the injection table, without mentioning hiccups. [1]

My teenager uses Wegovy® and gets hiccups. Is that described?

Not by name. In the adolescent trial, burping was reported by 4% on Wegovy® and 0% on placebo, and reflux by 4% and 2%, but hiccups are not listed. [1] Tell the prescriber if they persist.

How long is too long for hiccups?

Cleveland Clinic calls hiccups lasting more than 48 hours persistent and more than a month intractable, and advises contacting a provider after two days. [6]

Could reflux be behind my hiccups on Wegovy®?

Possibly. Reflux was more common on Wegovy® than placebo (5% vs 3%), [1] and reflux is a recognised cause of persistent hiccups. [6] Whether it explains your hiccups is something a clinician can assess.

Sources

Sources checked on

  1. WEGOVY® (semaglutide) injection and tablets Prescribing Information and Medication Guide, Novo Nordisk Revised 06/2026. Sections 2.2, 5.5, 6.1 (Tables 3–5 and gastrointestinal adverse reactions), 7.2 and Medication Guide.
  2. Wegovy: EPAR – Product Information (SmPC and package leaflet), European Medicines Agency Section 4.8, Table 3.
  3. WEGOVY® (semaglutide injection) Product Monograph, Novo Nordisk Canada Inc. Date of authorization 10 December 2025. Sections 8.2 (Table 4) and 8.3.
  4. Noh Y et al. Glucagon-like peptide-1 receptor agonists and risk for gastroesophageal reflux disease in patients with type 2 diabetes: a population-based cohort study. Ann Intern Med 2025 Observational cohort; PubMed abstract.
  5. Hiccups, MedlinePlus Medical Encyclopedia (U.S. National Library of Medicine)
  6. Hiccups, Cleveland Clinic
  7. Shu Y et al. Gastrointestinal adverse events associated with semaglutide: a pharmacovigilance study based on FDA adverse event reporting system. Front Public Health 2022 FAERS disproportionality analysis, 2018–2022; full text, Table 3. Reports do not show cause or frequency.

Keep exploring